Q32 Bio Inc. (QTTB) Short-term Investments (2017 - 2025)

Q32 Bio has reported Short-term Investments for 9 years, with the latest figure at $19.9 million in Q3 2025.

• On a quarterly basis, Short-term Investments changed N/A year-over-year to $19.9 million in Q3 2025; TTM through Sep 2025 was $19.9 million, a N/A change from a year earlier, with the FY2022 full-year figure at $141.0 million, up 196.98% from the prior year.
• Short-term Investments was $19.9 million for Q3 2025 at Q32 Bio, up from $10.0 million in the prior quarter.
• The five-year high for Short-term Investments was $157.9 million in Q3 2022, with the low at $8.0 million in Q1 2022.
• Average Short-term Investments over 5 years is $68.7 million, with a median of $62.2 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Short-term Investments tumbled 90.5% in 2022, then jumped 1282.31% in 2023.
• Over 5 years, Short-term Investments stood at $47.5 million in 2021, then surged by 196.98% to $141.0 million in 2022, then sank by 47.4% to $74.2 million in 2023, then sank by 86.54% to $10.0 million in 2024, then surged by 99.33% to $19.9 million in 2025.
• The last three Short-term Investments figures came in at $19.9 million (Q3 2025), $10.0 million (Q2 2024), and $19.8 million (Q1 2024), per Business Quant data.